Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 17/20 | 0.54 |
| ▸ | BCL2 | P10415 | 9/20 | 0.54 |
| ▸ | PMAIP1 | Q13794 | 7/20 | 0.54 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.53 |
| ▸ | ALB | P02768 | 1/20 | 0.53 |
| ▸ | BAD | Q92934 | 5/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19615213 | 0.82 | MCL1 (0.64) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635035 | 0.82 | MCL1 (0.57) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635033 | 0.81 | MCL1 (0.55) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635837 | 0.77 | MCL1 (0.61) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635839 | 0.76 | MCL1 (0.50) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19615080 | 0.76 | MCL1 (0.59) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635619 | 0.76 | MCL1 (0.58) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19615202 | 0.76 | MCL1 (0.64) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635358 | 0.76 | MCL1 (0.54) | MCL1BCL2PMAIP1BCL2L1ALB | |
| SCHEMBL19635987 | 0.75 | MCL1 (0.56) | MCL1BCL2PMAIP1BCL2L1BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458459-B1 | MACROCYCLIC INDOLE DERIVATIVES | BAYER AG (DE) | 2022-04-27 | — | — | EP | disclosed |
| WO-2017198341-A1 | MACROCYCLIC INDOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2017-11-23 | — | — | WO | disclosed |